BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18993078)

  • 1. Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes.
    Antonopoulou G; Barbayianni E; Magrioti V; Cotton N; Stephens D; Constantinou-Kokotou V; Dennis EA; Kokotos G
    Bioorg Med Chem; 2008 Dec; 16(24):10257-69. PubMed ID: 18993078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.
    Stephens D; Barbayianni E; Constantinou-Kokotou V; Peristeraki A; Six DA; Cooper J; Harkewicz R; Deems RA; Dennis EA; Kokotos G
    J Med Chem; 2006 May; 49(9):2821-8. PubMed ID: 16640343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides.
    Barbayianni E; Stephens D; Grkovich A; Magrioti V; Hsu YH; Dolatzas P; Kalogiannidis D; Dennis EA; Kokotos G
    Bioorg Med Chem; 2009 Jul; 17(13):4833-43. PubMed ID: 19443224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
    Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
    J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 2-oxoamides based on sulfonamide analogs of gamma-amino acids and their activity on phospholipase A2.
    Antonopoulou G; Magrioti V; Stephens D; Constantinou-Kokotou V; Dennis EA; Kokotos G
    J Pept Sci; 2008 Oct; 14(10):1111-20. PubMed ID: 18618424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A
    Smyrniotou A; Kokotou MG; Mouchlis VD; Barbayianni E; Kokotos G; Dennis EA; Constantinou-Kokotou V
    Bioorg Med Chem; 2017 Feb; 25(3):926-940. PubMed ID: 28034646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of secreted phospholipases A₂ by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.
    Mouchlis VD; Magrioti V; Barbayianni E; Cermak N; Oslund RC; Mavromoustakos TM; Gelb MH; Kokotos G
    Bioorg Med Chem; 2011 Jan; 19(2):735-43. PubMed ID: 21216150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity.
    Antonopoulou G; Magrioti V; Kokotou MG; Nikolaou A; Barbayianni E; Mouchlis VD; Dennis EA; Kokotos G
    Bioorg Med Chem; 2016 Oct; 24(19):4544-4554. PubMed ID: 27522578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 2-oxoamide inhibitors of human group IVA phospholipase A(2).
    Kokotos G; Kotsovolou S; Six DA; Constantinou-Kokotou V; Beltzner CC; Dennis EA
    J Med Chem; 2002 Jul; 45(14):2891-3. PubMed ID: 12086476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding conformation of 2-oxoamide inhibitors to group IVA cytosolic phospholipase A2 determined by molecular docking combined with molecular dynamics.
    Mouchlis VD; Michopoulou V; Constantinou-Kokotou V; Mavromoustakos T; Dennis EA; Kokotos G
    J Chem Inf Model; 2012 Jan; 52(1):243-54. PubMed ID: 22196172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2.
    Kokotos G; Hsu YH; Burke JE; Baskakis C; Kokotos CG; Magrioti V; Dennis EA
    J Med Chem; 2010 May; 53(9):3602-10. PubMed ID: 20369880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of lipophilic 2-oxoamides based on gamma-aminobutyric and delta-aminovaleric analogues and their activity against phospholipase A2.
    Moutevelis-Minakakis P; Neokosmidi A; Filippakou M; Stephens D; Dennis EA; Kokotos G
    J Pept Sci; 2007 Oct; 13(10):634-41. PubMed ID: 17631670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of secreted phospholipase A2 suppress the release of PGE2 in renal mesangial cells.
    Vasilakaki S; Barbayianni E; Magrioti V; Pastukhov O; Constantinou-Kokotou V; Huwiler A; Kokotos G
    Bioorg Med Chem; 2016 Jul; 24(13):3029-3034. PubMed ID: 27234891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis.
    Kalyvas A; Baskakis C; Magrioti V; Constantinou-Kokotou V; Stephens D; López-Vales R; Lu JQ; Yong VW; Dennis EA; Kokotos G; David S
    Brain; 2009 May; 132(Pt 5):1221-35. PubMed ID: 19218359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
    Vasilakaki S; Barbayianni E; Leonis G; Papadopoulos MG; Mavromoustakos T; Gelb MH; Kokotos G
    Bioorg Med Chem; 2016 Apr; 24(8):1683-95. PubMed ID: 26970660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase A2 superfamily members play divergent roles after spinal cord injury.
    López-Vales R; Ghasemlou N; Redensek A; Kerr BJ; Barbayianni E; Antonopoulou G; Baskakis C; Rathore KI; Constantinou-Kokotou V; Stephens D; Shimizu T; Dennis EA; Kokotos G; David S
    FASEB J; 2011 Dec; 25(12):4240-52. PubMed ID: 21868473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of group IVA cytosolic phospholipase A2 by novel 2-oxoamides in vitro, in cells, and in vivo.
    Kokotos G; Six DA; Loukas V; Smith T; Constantinou-Kokotou V; Hadjipavlou-Litina D; Kotsovolou S; Chiou A; Beltzner CC; Dennis EA
    J Med Chem; 2004 Jul; 47(14):3615-28. PubMed ID: 15214789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
    Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
    Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of rational design on phospholipase A(2) inhibitors.
    Mouchlis VD; Barbayianni E; Mavromoustakos TM; Kokotos G
    Curr Med Chem; 2011; 18(17):2566-82. PubMed ID: 21568891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates.
    Oslund RC; Gelb MH
    Biochemistry; 2012 Oct; 51(43):8617-26. PubMed ID: 23020658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.